Literature DB >> 15853947

Does childhood immunization against infectious diseases protect from the development of atopic disease?

Gilles Martignon1, Marie-Pierre Oryszczyn, Isabella Annesi-Maesano.   

Abstract

The argument of whether early immunization against infections promotes allergy or protects from it is presently under debate. The relationship between childhood immunization and the development of atopic diseases (asthma, allergic rhinitis and eczema) was examined in a population-based sample of 718 adolescents by taking individual data drawn from personal paediatric records on the schedule and the type of vaccination into account. Atopic diseases were determined using a standardized questionnaire. After adjustment for sex, age, father's socioeconomic status and active smoking, adolescents having been vaccinated (n = 694) had a significant lower risk to suffer from asthma or atopic diseases than non-vaccinated adolescents did (n = 24) [odds ratio (OR) = 0.30; 95% CI: 0.10, 0.92]. The relationship did not depend on the disease against which the vaccine was used as prophylaxis, the observance of the vaccination schedule or the number of inoculations. A higher protection was observed in the case of live attenuated vaccines (oral poliomyelitis and bacilli Camille-Guerin; OR = 0.26; 95% CI: 0.08, 0.83). These results, in agreement with previous ecological data, support the hypothesis that early vaccines could promote Th1 proliferation in response to the infectious agent contained in it, which inhibits the enhancement of atopic manifestations. Further studies are needed to confirm the phenomenon. Copyright 2005 Blackwell Munksgaard

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15853947     DOI: 10.1111/j.1399-3038.2005.00254.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  6 in total

Review 1.  The potential of Mycobacterium to protect against allergy and asthma.

Authors:  Charles C Obihara; Jan L L Kimpen; Nulda Beyers
Journal:  Curr Allergy Asthma Rep       Date:  2007-06       Impact factor: 4.806

Review 2.  Mycobacterium-Induced Th1, Helminths-Induced Th2 Cells and the Potential Vaccine Candidates for Allergic Asthma: Imitation of Natural Infection.

Authors:  Mohamed Hamed Abdelaziz; Xiaoyun Ji; Jie Wan; Fatma A Abouelnazar; Sayed F Abdelwahab; Huaxi Xu
Journal:  Front Immunol       Date:  2021-08-03       Impact factor: 7.561

3.  Pertussis immunization in infancy and adolescent asthma medication.

Authors:  Hartmut Vogt; Lennart Bråbäck; Anna-Maria Kling; Maria Grünewald; Lennart Nilsson
Journal:  Pediatrics       Date:  2014-09-22       Impact factor: 7.124

4.  Single systemic administration of Ag85B of mycobacteria DNA inhibits allergic airway inflammation in a mouse model of asthma.

Authors:  Katsuo Karamatsu; Kazuhiro Matsuo; Hiroyasu Inada; Yusuke Tsujimura; Yumiko Shiogama; Akihiro Matsubara; Mitsuo Kawano; Yasuhiro Yasutomi
Journal:  J Asthma Allergy       Date:  2012-12-03

Review 5.  Role of primary and secondary prevention in atopic dermatitis.

Authors:  Magdalena Oszukowska; Iwonna Michalak; Katarzyna Gutfreund; Wojciech Bienias; Marta Matych; Anna Szewczyk; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

6.  Clinical efficacy and laboratory improvement of bacillus calmette-guerin vaccination on adult atopic asthma: a cohort study.

Authors:  Eulis A Datau; H Mewengkang; J C Matheos; I Purnawan; M Wibisono; K Wongdjaja; C Wibowo; E Surachmanto; F P Salim
Journal:  World Allergy Organ J       Date:  2008-04       Impact factor: 4.084

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.